American Psychiatric Association. Diagnostic, Statistical Manual of Mental of Disorders, 4thText Revision (DSM-IV-TR)Washington, DC: American Psychiatric Association, 2000.
2.
BeckerME, HertzbergMA, MooreSD, DennisMF, BukenyaDS, BeckhamJC. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol, 27:193–197. 2007.
3.
BellevilleG, GuayS, MarchandA. Impact of sleep disturbances on PTSD symptoms and perceived health. J Nerv Ment Dis, 197:126–132. 2009.
4.
BrkanacZ, PastorJF, StorckM. Prazosin in PTSD. J Am Acad Child Adolesc Psychiatry, 42:384–385. 2003.
5.
ByersMG, AllisonKM, WendelCS, LeeJK. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: An assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol, 30:225–229. 2010.
6.
CaldwellBA, RedekerN. Sleep and trauma: An overview. Issues Ment Health Nurs, 26:721–738. 2005.
7.
CharuvastraA, CloitreM. Safe enough to sleep: sleep disruptions associated with trauma, posttraumatic stress, and anxiety in children and adolescents. Child Adolesc Psychiatr Clin N Am, 18:877–891. 2009.
8.
CohenJA, MannarinoAP, PerelJM, StaronV. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry, 46:811–819. 2007.
9.
CostelloEJ, AngoldA, BurnsBJ, StanglDK, TweedDL, ErkanliA, WorthmanCM. The Great Smoky Mountains Study of Youth: Goals, designs, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry, 53:1129–1136. 1996.
10.
DaveyJM. The pharmacology of prazosin, an alpha 1-adrenoceptor antagonist and the basis for its use in the treatment of essential hypertension. Clin Exp Hypertens A, 4:47–59. 1982.
11.
DavidsonJR, RothbaumBO, Van der KolkBA, SikesCR, FarfelGM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry, 58:485–492. 2001.
12.
FitzpatrickKM, BoldizarJP. The prevalence and consequences of exposure to violence among African-American youth. J Am Acad Child Adolesc Psychiatry, 32:424–430. 1993.
13.
FordT, GoodmanR, MeltzerH. Service over 18 months among a nationally representative sample of British children with psychiatric disorder. Clin Child Psychol Psychiatry, 8:37–51. 2003.
14.
FraleighLA, HendrattaVD, FordJD, ConnorDF. Prazosin for the treatment of posttraumatic stress disorder-related nightmares in an adolescent male. J Child Adolesc Psychopharmacol, 19:475–476. 2009.
15.
HamblenJ. PTSD in Children and Adolescents, National Center for PTSD. U.S Department of Veterans Affairs. 2011. www.ptsd.va.gov/professional/pages/ptsd_in_children_and_adolescents_overview_for_professionals.asp. 2012 May 15.
16.
HamblenJ, BarnettE. Trauma, PTSD and Attachment in Infants and Young Children. PTSD in Children and Teens. The National Center for PTSD. U.S. Department of Veterans Affairs. NCPTSD, 2009. www.ptsd.va.gov/professional/pages/trauma_ptsd_attachment.asp. 2012 May 14.
17.
HarmonRJ, RiggsPD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry, 35:1247–1249. 1996.
18.
HorriganJP, BarnhillLJ. The suppression of nightmares with guanfacine. J Clin Psychiatry, 57:371. 1996.
19.
HorriganJP. Guanfacine for PTSD nightmares. J Am Acad Child Adolesc Psychiatry, 35:975–976. 1996.
20.
JaillonP. Clinical pharmacokinetics of prazosin. Clin Pharmacokinet, 5:365–376. 1998.
21.
JeffreysM. Clinician's Guide to Medications for PTSD. National Center for PTSD. U.S Department of Veterans Affairs. 2009. www.ptsd.va.gov/professional/pages/clinicians-guide-to-medications-for-ptsd.asp. 2012 May 10.
KilpatrickDG, RuggieroKJ, AciernoR, SaundersB, ResnickHS, BestCL. Violence and risk of PTSD, major depression, substance abuse/dependence, and comorbidity: Results from the National Survey of Adolescents. J Consult Clin Psychol, 71:692–700. 2003.
24.
La GrecaAM, SilvermanWS, VernbergEM, Prinstein MJ. Posttraumatic stress symptoms in children after Hurricane Andrew: A prospective study. J Consult Clin Psychol, 64:712–723. 1996.
25.
McLeerSV, CallaghanM, HenryD, WallenJ. Psychiatric disorders in sexually abused children. J Am Acad Child Adolesc Psychiatry, 33:313–319. 1994.
26.
MedinaJJ. Neurobiology of PTSD: Part 1. Psychiatr Times, 25:29–34. 2008a.
27.
MedinaJJ. Neurobiology of PTSD: Part 2. Psychiatr Times, 25:18–20. 2008b.
28.
MeewisseML, ReitsmaJB, de VriesGJ, GersonsBP, OlffM. Cortisol and post-traumatic stress disorder in adults: Systematic review and meta-analysis. Br J Psychiatry, 191:387–392. 2007.
29.
MillerLJ. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances. Pharmacotherapy, 28:656–666. 2008.
30.
National Center for PTSD. PTSD in Children and Teens. The National Center for PTSD, U.S. Department of Veterans Affairs. NCPTSD, 2007. ptsd.va.gov/public/pages/ptsd-children-adolescents.asp. 2012 May 14.
NugentNR. The efficacy of early propranolol administration at preventing/reducing PTSD symptoms in child trauma victims: Pilot (dissertation)Kent State University: Kent, Ohio, 2007. etd.ohiolink.edu/send-pdf.cgi/Nugent%20Nicole%20Renee.pdf?kent1182616758. 2012 May 16.
33.
PerryBD. Neurobiological sequelae of childhood trauma: PTSD in children. Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts. MurburgM. M.1994; 233–255. Washington, DC: American Psychiatric Press.
34.
PorterDM, BellCC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc, 91:475–477. 1999.
35.
RaskindMA, PeskindER, KanterED, PetrieEC, RadantA, ThompsonCE, DobieDJ, HoffD, ReinRJ, Straits–TrösterK, ThomasRG, McFallMM. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin. Am J Psychiatry, 160:371–373. 2003.
36.
RobbAS, CuevaJE, SpornJ, YangR, VanderburgDG. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharrnacol, 20:463–471. 2010.
37.
StrawnJR, DelBelloMP, GeraciotiTD. Prazosin treatment of an adolescent with posttraumatic stress disorder. J Child Adolescent Psychopharmacol, 19:599–600. 2009.
38.
StrawnJR, KeeshinBR. Successful treatment of posttraumatic stress disorder with prazosin in a young child. Ann Pharmacother, 45:1590–1591. 2011.
39.
StrawnJR, KeeshinBR, DelBelloMP, Geracioti TDJr, PutnamFW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry, 71:932–941. 2010.
40.
TaylorRH, FreemanM, CatesEM. Prazosin for treatment of nightmares related to posttraumatic stress disorder. Am J Health Syst Pharm, 65:716–722. 2008.
41.
United States Food and Drug Administration: Prazosin hydrochloride. Safety Labeling by U.S. Food and Drug Administration, FDA Center for Drug Evaluation and Research (CDER)2009. www.fda.gov/Safety/MedWatch/SafetyInformation/ucm175812.htm. 2012 June 7.
42.
YehudaR, TeicherMH, SecklJR, GrossmanRA, MorrisA, BiererLM. Parental posttraumatic stress disorder as a vulnerability factor for low cortisol trait in offspring of Holocaust survivors. Arch Gen Psychiatry, 64:1040–1048. 2007.